VIVS – vivosim labs, inc. (US:NASDAQ)
Stock Stats
News
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China [Yahoo! Finance]
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
VivoSim Labs (NASDAQ:VIVS) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
3D Bioprinting Market Size to Surpass USD 8.57 Billion by 2034 [Yahoo! Finance]
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Cohen Douglas Jay
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Murphy Keith
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Milhous Alison Tjosvold
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: Gobel David
Form 4 VivoSim Labs, INC. For: Jan 27 Filed by: STERN ADAM K
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.